| Dataset | DGIdb Drug Targets 2026 |
| Category | physical interactions |
| Type | drug |
| Description | An azaspiro compound that consists of 1,3,8-triazaspiro[4.5]decan-4-one having a phenyl group attached to N-1 and a 3-(4-fluorophenoxy)propyl attached to N-8. Selective 5-HT antagonist, which binds to 5-HT2 sites as potently as spiperone but has lower affinity for 5-HT2C receptors. Also a high affinity D2 receptor antagonist (Ki = 3 nM). Lacks the disruptive effect of spiperone on animal behaviour. (Chemical Entities of Biological Interest Ontology, CHEBI_64207) |
| External Link | https://dgidb.org/results?searchType=drug&searchTerms=SPIRAMIDE |
| Similar Terms | |
| Downloads & Tools |
6 interacting proteins for the SPIRAMIDE drug from theDGIdb Drug Targets 2026 dataset.
| Symbol | Name | Standardized Value |
|---|---|---|
| HTR2B | 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled | 0.0747627 |
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | 0.0608414 |
| HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled | 0.0404679 |
| CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 0.0144386 |
| NFE2L2 | nuclear factor, erythroid 2-like 2 | 0.0104899 |
| AR | androgen receptor | 0.00994588 |